GCK gene mutations are a common cause of childhood-onset MODY (maturity-onset diabetes of the young) in Turkey

被引:21
作者
Haliloglu, Belma [1 ,2 ]
Hysenaj, Gerald [2 ]
Atay, Zeynep [1 ]
Guran, Tulay [1 ]
Abali, Saygin [1 ]
Turan, Serap [1 ]
Bereket, Abdullah [1 ]
Ellard, Sian [2 ]
机构
[1] Marmara Univ, Dept Pediat Endocrinol, Sch Med, Fevzi Cakmak Mah Muhsin Yazicioglu Cad 10, TR-34899 Istanbul, Turkey
[2] Univ Exeter, Inst Biomed & Clin Sci, Sch Med, Exeter, Devon, England
关键词
GLUCOKINASE MUTATIONS; PREVALENCE; CHILDREN; MELLITUS; DIAGNOSIS; FAMILIES; CAMPAIGN; COHORT;
D O I
10.1111/cen.13121
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveInactivating heterozygous mutations in the GCK gene are a common cause of MODY and result in mild fasting hyperglycaemia, which does not require treatment. We aimed to identify the frequency, clinical and molecular features of GCK mutations in a Turkish paediatric cohort. Design and PatientsFifty-four unrelated probands were selected based on the following criteria: age of diagnosis 17years, family history of diabetes in at least two generations, anti-GAD/ICA negative, BMI<95.p and follow-up with diet, oral antidiabetic drug or low-dose insulin treatment (05U/kg/d). A MODY probability score () was calculated and 21 patients with a score 75%, HbA1c levels 75% (585mmol/mol) and fasting blood glucose (FBG) levels 99-145mg/dl (55-80mmol/l) were selected for Sanger sequencing of the GCK gene. Targeted next-generation sequencing for all known monogenic diabetes genes was undertaken for any patient without a GCK gene mutation. ResultsGCK gene mutations (pathogenic or likely pathogenic variants) and a novel intronic variant of uncertain significance (c.208+3A>T) were identified in 13/54 probands (24%). Twelve of these patients had a MODY probability score 75%. FBG level and 2-h glucose level in OGTT were 12314mg/dl (68 +/- 07mmol/l) (107-157mg/dl) and 181 +/- 30mg/dl (101 +/- 16mmol/l) (136-247mg/dl), respectively. Average of glucose increment in OGTT was 58 +/- 27mg/dl (32 +/- 15mmol/l) (19-120mg/dl), and mean HbA1c level was 65 +/- 05% (475 +/- 55mmol/mol) (59-76%). Five novel missense mutations were identified (p.F123S, p.L58P, p.G246A, p.F419C, and p.S151C). Two patients treated with low-dose insulin before the molecular analysis were able to stop treatment. ConclusionsApproximately 1 in 4 MODY cases in this Turkish paediatric cohort have a GCK mutation. Selection of patients for GCK gene analysis using the MODY probability score was an effective way of identifying most (11/12) patients with a GCK mutation.
引用
收藏
页码:393 / 399
页数:7
相关论文
共 27 条
[1]   Interaction of glucokinase with the liver regulatory protein is conferred by leucine-asparagine motifs of the enzyme [J].
Baltrusch, S ;
Francini, F ;
Lenzen, S ;
Tiedge, M .
DIABETES, 2005, 54 (10) :2829-2837
[2]   Nine novel mutations in maturity-onset diabetes of the young (MODY) candidate genes in 22 Spanish families [J].
Barrio, R ;
Bellanné-Chantelot, C ;
Moreno, JC ;
Morel, V ;
Calle, H ;
Alonso, M ;
Mustieles, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (06) :2532-2539
[3]   Doubling the referral rate of monogenic diabetes through a nationwide information campaign - update on glucokinase gene mutations in a Polish cohort [J].
Borowiec, M. ;
Fendler, W. ;
Antosik, K. ;
Baranowska, A. ;
Gnys, P. ;
Zmyslowska, A. ;
Malecki, M. ;
Mlynarski, W. .
CLINICAL GENETICS, 2012, 82 (06) :587-590
[4]   The 0.1% of the Population With Glucokinase Monogenic Diabetes Can Be Recognized by Clinical Characteristics in Pregnancy: The Atlantic Diabetes in Pregnancy Cohort [J].
Chakera, Ali J. ;
Spyer, Gill ;
Vincent, Nicola ;
Ellard, Sian ;
Hattersley, Andrew T. ;
Dunne, Fidelma P. .
DIABETES CARE, 2014, 37 (05) :1230-1236
[5]   Clinical Heterogeneity in Monogenic Diabetes Caused by Mutations in the Glucokinase Gene (GCK-MODY) [J].
Cuesta-Munoz, Antonio L. ;
Tuomi, Tiinamaija ;
Cobo-Vuilleumier, Nadia ;
Koskela, Hanna ;
Odili, Stella ;
Stride, Amanda ;
Buettger, Carol ;
Otonkoski, Timo ;
Froguel, Philippe ;
Grimsby, Joseph ;
Garcia-Gimeno, Maria ;
Matschinsky, Franz M. .
DIABETES CARE, 2010, 33 (02) :290-292
[6]   Improved genetic testing for monogenic diabetes using targeted next-generation sequencing [J].
Ellard, S. ;
Allen, H. Lango ;
De Franco, E. ;
Flanagan, S. E. ;
Hysenaj, G. ;
Colclough, K. ;
Houghton, J. A. L. ;
Shepherd, M. ;
Hattersley, A. T. ;
Weedon, M. N. ;
Caswell, R. .
DIABETOLOGIA, 2013, 56 (09) :1958-1963
[7]   Mutations in GCK and HNF-1α explain the majority of cases with clinical diagnosis of MODY in Spain [J].
Estalella, Itziar ;
Rica, Itxaso ;
de Nanclares, Guiomar Perez ;
Bilbao, Jose Ramon ;
Vazquez, Jose Antonio ;
San Pedro, Jose Ignacio ;
Busturia, Maria Angeles ;
Castano, Luis .
CLINICAL ENDOCRINOLOGY, 2007, 67 (04) :538-546
[8]   Prevalence of monogenic diabetes amongst Polish children after a nationwide genetic screening campaign [J].
Fendler, W. ;
Borowiec, M. ;
Baranowska-Jazwiecka, A. ;
Szadkowska, A. ;
Skala-Zamorowska, E. ;
Deja, G. ;
Jarosz-Chobot, P. ;
Techmanska, I. ;
Bautembach-Minkowska, J. ;
Mysliwiec, M. ;
Zmyslowska, A. ;
Pietrzak, I. ;
Malecki, M. T. ;
Mlynarski, W. .
DIABETOLOGIA, 2012, 55 (10) :2631-2635
[9]   Haploinsufficiency at GCK gene is not a frequent event in MODY2 patients [J].
Garin, Intza ;
Rica, Itxaso ;
Estalella, Itziar ;
Oyarzabal, Mirentxu ;
Rodriguez-Rigual, Mercedes ;
Pedro, Jose Ignacio San ;
Perez-Nanclares, Gustavo ;
Fernandez-Rebollo, Eduardo ;
Busturia, Maria Angeles ;
Castano, Luis ;
de Nanclares, Guiomar Perez .
CLINICAL ENDOCRINOLOGY, 2008, 68 (06) :873-878
[10]  
Guazzarotti L, 2001, J PEDIATR ENDOCR MET, V14, P611